Literature DB >> 22922099

Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution.

Kanokthip Boonyarattanakalin1, Peter Wolschann, Pisanu Toochinda, Luckhana Lawtrakul.   

Abstract

The inclusion complexes of highly potent anti-HIV agent, UC781, with β-cyclodextrin (βCD), 2,6-dimethyl-β-cyclodextrin (MβCD), and 2-hydroxypropyl-β-cyclodextrin (HPβCD) in aqueous solution were investigated by molecular dynamics simulations. Simulations show that the phenyl ring of UC781 is trapped inside CD cavities, while the NH group of UC781 interacts with secondary hydroxyl groups at the wider rim of CDs. The different types of CDs directly affect the binding energy and the stability of the inclusion complexes. MβCD provides the most stable inclusion complex of UC781 among all CDs in this study due to the effect of methoxy groups (-OCH(3)) at C2 and C6 positions on the glucopyranose of CDs. Structure analysis of CDs and the orientation of UC781 inside CD cavities as well as the effects of aqueous solution to the inclusion complexes of UC781/CDs are discussed. Results of this study have provided an agreeable output; therefore, a reliable prediction method for other drug/CD inclusion complex formations is introduced.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922099     DOI: 10.1016/j.ejps.2012.08.004

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

1.  Binding mode and free energy prediction of fisetin/β-cyclodextrin inclusion complexes.

Authors:  Bodee Nutho; Wasinee Khuntawee; Chompoonut Rungnim; Piamsook Pongsawasdi; Peter Wolschann; Alfred Karpfen; Nawee Kungwan; Thanyada Rungrotmongkol
Journal:  Beilstein J Org Chem       Date:  2014-11-27       Impact factor: 2.883

2.  Influence of Ethanol as a Co-Solvent in Cyclodextrin Inclusion Complexation: A Molecular Dynamics Study.

Authors:  Kanokthip Boonyarattanakalin; Helmut Viernstein; Peter Wolschann; Luckhana Lawtrakul
Journal:  Sci Pharm       Date:  2015-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.